Clinical Trials 2.0: The Impact of Digitisation
Digitised healthcare is a compelling proposition for industry stakeholders today, since it carries with it the promise of enhanced consumer benefits and operational efficiencies alike. There are several clinical trial innovations that digitisation has enabled in recent years, paving the way forward towards better data integration, virtual clinical trials, eClinical solutions and patient-centric trials. Digital health technologies have shown their propensity towards boosting objective data collection in trials, scaling up patient access, and facilitating improvements in terms of clinical outcomes. Here’s taking a closer look at digitisation and its overall impact in this space. Recruiting and Retaining Participants in Clinical Trials Digitised healthcare technologies have a leading part to play in terms of participant retention and recruitment for clinical trials. Here are some aspects worth noting in this regard: Here’s taking a closer look at how technology impacts clinical trials in the current landscape. How does technology affect clinical trials? Here are a few pointers that illustrate the impact of technology on clinical trials. Now that the positive effects of technology on clinical trials are visible, let us take a closer look at the impact of digitalisation on healthcare. How does digitalisation affect healthcare? Digitalisation-driven healthcare or digitised healthcare, whichever way you choose to see it, will eventually be the future for the entire ecosystem. This is how digitalisation affects healthcare in multifarious ways: FAQs 1. How are cutting-edge technologies like AI and IoT contributing to the success of Clinical Trials 2.0? IoT is already contributing towards better clinical trials through enabling easy monitoring and gathering of information that can be swiftly accessed in real-time. AI is also identifying and screening potential trial participants based on diverse criteria. Both technologies are reducing costs and timelines for patient recruitment and data gathering alike. They are also making clinical trials more accessible and user-friendly. 2. Can you elaborate on the advantages of virtual and decentralised clinical trials in the context of digitisation? Decentralised and virtual clinical trials are enabling easier access to participants across remote and under-served areas/sites. Remote data gathering and monitoring is one advantage along with combating logistical, transportation, and access hurdles. There is also the opportunity to access bigger and more diverse populations with these trial systems. These are some of the biggest advantages of virtual clinical trials. 3. What challenges arise in adapting legacy systems to the demands of digitised clinical trial processes? Legacy systems need to be adapted to digitised clinical trial processes in the current scenario. Some of the major challenges in this case include software and technological costs, awareness and education on new technological procedures, choosing suitable technologies, and technological literacy of participants. 4. What role does real-world data integration play in driving insights and innovation within digitised clinical trials? Real-world data integration plays a crucial role in enabling greater innovation and insights as far as digitised clinical trials are concerned. Wearables, remote tracking, and virtual clinical visits may enable more patient-focused trials. This will enhance patient engagement greatly while enabling higher accuracy in terms of insights on how medicines perform in actual settings and scenarios.